Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation

Aliprantis, 2008, NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism, J Clin Invest, 118, 3775, 10.1172/JCI35711

Asagiri, 2007, The molecular understanding of osteoclast differentiation, Bone, 40, 251, 10.1016/j.bone.2006.09.023

Asagiri, 2005, Autoamplification of NFATc1 expression determines its essential role in bone homeostasis, J Exp Med, 202, 1261, 10.1084/jem.20051150

Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658

Cella, 2003, Impaired differentiation of osteoclasts in TREM-2-deficient individuals, J Exp Med, 198, 645, 10.1084/jem.20022220

Chambers, 2011, How are osteoclasts induced to resorb bone? Ann, N Y Acad Sci, 1240, 1, 10.1111/j.1749-6632.2011.06249.x

Cheng, 2003, The TNF receptor superfamily: role in immune inflammation and bone formation, Immunol Res, 27, 287, 10.1385/IR:27:2-3:287

Choi, 2013, Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis, Cell Res, 23, 524, 10.1038/cr.2013.33

Darnay, 1998, Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase, J Biol Chem, 273, 20551, 10.1074/jbc.273.32.20551

David, 2002, JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and-independent mechanisms, J Cell Sci, 115, 4317, 10.1242/jcs.00082

Dougall, 1999, RANK is essential for osteoclast and lymph node development, Genes Dev, 13, 2412, 10.1101/gad.13.18.2412

Duran, 2004, The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis, Dev Cell, 6, 303, 10.1016/S1534-5807(03)00403-9

Faccio, 2005, Vav3 regulates osteoclast function and bone mass, Nat Med, 11, 284, 10.1038/nm1194

Franzoso, 1997, Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev, 11, 3482, 10.1101/gad.11.24.3482

Fumoto, 2014, Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis, J Bone Miner Res, 29, 830, 10.1002/jbmr.2096

Ghosh, 2002, Missing pieces in the NF-kappaB puzzle, Cell, 109, S81, 10.1016/S0092-8674(02)00703-1

Grigoriadis, 1994, c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling, Science, 266, 443, 10.1126/science.7939685

He, 2011, Erk1 positively regulates osteoclast differentiation and bone resorptive activity, PLoS One, 6, e24780, 10.1371/journal.pone.0024780

Hogan, 2003, Transcriptional regulation by calcium, calcineurin, and NFAT, Genes Dev, 17, 2205, 10.1101/gad.1102703

Humphrey, 2006, TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function, J Bone Miner Res, 21, 237, 10.1359/JBMR.051016

Ikeda, 2004, Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation, J Clin Invest, 114, 475, 10.1172/JCI200419657

Iotsova, 1997, Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2, Nat Med, 3, 1285, 10.1038/nm1197-1285

Jang, 2011, Inactivation of glycogen synthase kinase-3beta is required for osteoclast differentiation, J Biol Chem, 286, 39043, 10.1074/jbc.M111.256768

Karsenty, 2002, Reaching a genetic and molecular understanding of skeletal development, Dev Cell, 2, 389, 10.1016/S1534-5807(02)00157-0

Kim, 2002, A novel member of the leukocyte receptor complex regulates osteoclast differentiation, J Exp Med, 195, 201, 10.1084/jem.20011681

Kim, 2007, MafB negatively regulates RANKL-mediated osteoclast differentiation, Blood, 109, 3253, 10.1182/blood-2006-09-048249

Kim, 2008, NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP), Mol Endocrinol, 22, 176, 10.1210/me.2007-0237

Kim, 2009, Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice, J Clin Invest, 119, 813, 10.1172/JCI36809

Kobayashi, 2001, Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis, EMBO J, 20, 1271, 10.1093/emboj/20.6.1271

Koga, 2004, Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis, Nature, 428, 758, 10.1038/nature02444

Koga, 2005, NFAT and Osterix cooperatively regulate bone formation, Nat Med, 11, 880, 10.1038/nm1270

Kong, 1999, Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, 402, 304, 10.1038/46303

Lee, 2005, A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation, Blood, 106, 852, 10.1182/blood-2004-09-3662

Li, 2000, RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism, Proc Natl Acad Sci USA, 97, 1566, 10.1073/pnas.97.4.1566

Li, 2002, p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function, Endocrinology, 143, 3105, 10.1210/endo.143.8.8954

Lin, 2015, The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors, Sci Signal, 8, ra54, 10.1126/scisignal.2005867

Lomaga, 1999, TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling, Genes Dev, 13, 1015, 10.1101/gad.13.8.1015

Mao, 2006, PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2, J Clin Invest, 116, 2869, 10.1172/JCI28775

Matsumoto, 2004, Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1, J Biol Chem, 279, 45969, 10.1074/jbc.M408795200

Miyauchi, 2010, The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis, J Exp Med, 207, 751, 10.1084/jem.20091957

Mizukami, 2002, Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6, Mol Cell Biol, 22, 992, 10.1128/MCB.22.4.992-1000.2002

Moon, 2012, Akt induces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade, J Immunol, 188, 163, 10.4049/jimmunol.1101254

Naito, 1999, Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice, Genes Cells, 4, 353, 10.1046/j.1365-2443.1999.00265.x

Nakashima, 2011, Evidence for osteocyte regulation of bone homeostasis through RANKL expression, Nat Med, 17, 1231, 10.1038/nm.2452

Ninomiya-Tsuji, 1999, The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway, Nature, 398, 252, 10.1038/18465

Nishikawa, 2010, Blimp1-mediated repression of negative regulators is required for osteoclast differentiation, Proc Natl Acad Sci USA, 107, 3117, 10.1073/pnas.0912779107

Oikawa, 2012, Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion, J Cell Biol, 197, 553, 10.1083/jcb.201111116

Park, 2016, Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation, Sci Rep, 6, 26186, 10.1038/srep26186

Putney, 2005, Capacitative calcium entry: sensing the calcium stores, J Cell Biol, 169, 381, 10.1083/jcb.200503161

Sheridan, 2002, Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3, J Biol Chem, 277, 48664, 10.1074/jbc.M207029200

Shin, 2014, PKCbeta positively regulates RANKL-induced osteoclastogenesis by inactivating GSK-3beta, Mol Cells, 37, 747, 10.14348/molcells.2014.0220

Shinohara, 2008, Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals, Cell, 132, 794, 10.1016/j.cell.2007.12.037

Taguchi, 2009, A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals, Genes Cells, 14, 1331, 10.1111/j.1365-2443.2009.01351.x

Takayanagi, 2002, Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts, Dev Cell, 3, 889, 10.1016/S1534-5807(02)00369-6

Teitelbaum, 2000, Bone resorption by osteoclasts, Science, 289, 1504, 10.1126/science.289.5484.1504

Teitelbaum, 2003, Genetic regulation of osteoclast development and function, Nat Rev Genet, 4, 638, 10.1038/nrg1122

Vaananen, 1990, Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts, J Cell Biol, 111, 1305, 10.1083/jcb.111.3.1305

Wada, 2005, The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis, Nat Med, 11, 394, 10.1038/nm1203

Wagner, 2002, Functions of AP1 (Fos/Jun) in bone development, Ann Rheum Dis, 61, ii40, 10.1136/ard.61.suppl_2.ii40

Wang, 1992, Bone and haematopoietic defects in mice lacking c-fos, Nature, 360, 741, 10.1038/360741a0

Wong, 1998, The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor, J Biol Chem, 273, 28355, 10.1074/jbc.273.43.28355

Wong, 1999, TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src, Mol Cell, 4, 1041, 10.1016/S1097-2765(00)80232-4

Xiong, 2011, Matrix-embedded cells control osteoclast formation, Nat Med, 17, 1235, 10.1038/nm.2448

Yagi, 2007, Induction of DC-STAMP by alternative activation and downstream signaling mechanisms, J Bone Miner Res, 22, 992, 10.1359/jbmr.070401

Yamashita, 2007, NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1, J Biol Chem, 282, 18245, 10.1074/jbc.M610701200

Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci USA, 95, 3597, 10.1073/pnas.95.7.3597

Ye, 2002, Distinct molecular mechanism for initiating TRAF6 signalling, Nature, 418, 443, 10.1038/nature00888

Zaidi, 2007, Skeletal remodeling in health and disease, Nat Med, 13, 791, 10.1038/nm1593

Zhao, 2009, Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis, Nat Med, 15, 1066, 10.1038/nm.2007

Zou, 2007, Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption, J Cell Biol, 176, 877, 10.1083/jcb.200611083